Literature DB >> 8512019

Diffuse leptomeningeal melanomatosis of the spinal cord: a case report.

P Gaetani1, A Martelli, F Sessa, F Zappoli, R Rodriguez.   

Abstract

A rare case of diffuse leptomeningeal melanosis presenting with symptoms of spinal cord compression due to the presence of anterolateral arachnoid cyst and treated with Spetzler's drainage system is reported. The diagnosis of diffuse melanosis of the leptomeninges is rarely possible during life. In the present case MRI was of great help in the definition of the limits of the pathological process and the presence of the anterior compressing cyst. After laminectomy and a biopsy of the pathological tissue which achieved the histological diagnosis, an external drainage was inserted to reduce the cyst extension and to exclude the presence of melanocytes in the cystic fluid before a peritoneal shunt was placed. At 8th month of follow-up the patient is doing well with a dramatic reduction of symptoms and a significant reduction of spinal cord compression. The diagnostic role of MRI and the relationship between leptomeningeal melanosis and arachnoid cyst are discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8512019     DOI: 10.1007/BF01809277

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  19 in total

1.  Primary leptomeningeal melanomatosis presenting as carcinomatous meningitis.

Authors:  M H Savitz; S Gendelman; Y P Huang; A O Fayemi; P J Anderson
Journal:  Mt Sinai J Med       Date:  1974 Nov-Dec

Review 2.  Primary melanoma of the leptomeninges: a review.

Authors:  M H Savitz; P J Anderson
Journal:  Mt Sinai J Med       Date:  1974 Nov-Dec

3.  Neurocutaneous melanosis and leptomeningeal melanomatosis in children.

Authors:  J C Slaughter; J M Hardman; L G Kempe; K M Earle
Journal:  Arch Pathol       Date:  1969-09

4.  Primary melanocytoblastoma of the leptomeninges.

Authors:  P Engelhardt; W Lang
Journal:  J Neurol       Date:  1977-04-28       Impact factor: 4.849

5.  Primary malignant melanomatosis of the meninges. Clinical course and computed tomographic findings in a young child.

Authors:  D E Crisp; J A Thompson
Journal:  Arch Neurol       Date:  1981-08

6.  Primary malignant melanomatosis of leptomeninges.

Authors:  G Tolnai; J S Campbell; D P Hill; E W Peterson; A J Hudson; F W Luney
Journal:  Arch Neurol       Date:  1966-10

7.  Neuroradiological findings in a child with primary leptomeningeal melanoma.

Authors:  O Flodmark; C R Fitz; D C Harwood-Nash; S H Chuang
Journal:  Neuroradiology       Date:  1979-09-26       Impact factor: 2.804

8.  Intracerebral malignant melanoma: high-field-strength MR imaging.

Authors:  W W Woodruff; W T Djang; R E McLendon; E R Heinz; D R Voorhees
Journal:  Radiology       Date:  1987-10       Impact factor: 11.105

9.  Amelanotic leptomeningeal melanoblastosis. Case report.

Authors:  G Bussone; L La Mantia; M A Vaghi; L Grazzi; E Lamperti; F Pluchino; A Allegranza
Journal:  Ital J Neurol Sci       Date:  1990-04

10.  Primary leptomeningeal melanoma: an ultrastructural study.

Authors:  S W Silbert; K R Smith; S Horenstein
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

View more
  3 in total

1.  Primary melanocytic tumors of the central nervous system: Report of two cases and review of literature.

Authors:  Victoria Trinh; Rafael Medina-Flores; Chirstopher L Taylor; Howard Yonas; Muhammad O Chohan
Journal:  Surg Neurol Int       Date:  2014-10-13

2.  F-18 fluorodeoxyglucose PET/CT and post hoc PET/MRI in a case of primary meningeal melanomatosis.

Authors:  Hong Je Lee; Byeong-Cheol Ahn; Seong Wook Hwang; Suk Kyong Cho; Hae Won Kim; Sang-Woo Lee; Jeong-Hyun Hwang; Jaetae Lee
Journal:  Korean J Radiol       Date:  2013-02-22       Impact factor: 3.500

3.  Adult male with multiple cranial nerve palsies.

Authors:  S V Khadilkar; A H Harish; Padhy Bimal Prasad; Jaggi Sunila; Girish Muzumdar; B K Smruti; C E Devpujari
Journal:  Ann Indian Acad Neurol       Date:  2012-04       Impact factor: 1.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.